- Home
- OCS vs PMT Comparison
OCS vs PMT Comparison
Compare OCS & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | PMT |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 812.7M |
| IPO Year | 2022 | 2009 |
Fundamental Metrics
Financial Performance| Metric | OCS | PMT |
|---|---|---|
| Price | $10.07 | $9.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $42.00 | $13.50 |
| AVG Volume (30 Days) | 142.9K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $351,067,000.00 |
| Revenue This Year | $466.06 | N/A |
| Revenue Next Year | $479.73 | $1.55 |
| P/E Ratio | ★ N/A | $22.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.50 | $9.05 |
| 52 Week High | $34.48 | $13.80 |
Technical Indicators
Market Signals| Indicator | OCS | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 24.29 | 36.42 |
| Support Level | N/A | N/A |
| Resistance Level | $13.49 | $9.76 |
| Average True Range (ATR) | 0.53 | 0.16 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 3.42 | 8.28 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.